D
David Cohen
Researcher at Pierre-and-Marie-Curie University
Publications - 787
Citations - 45536
David Cohen is an academic researcher from Pierre-and-Marie-Curie University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 83, co-authored 635 publications receiving 37722 citations. Previous affiliations of David Cohen include University of California, Berkeley & University of Michigan.
Papers
More filters
Journal ArticleDOI
Economic analysis of angiography and preemptive angioplasty to prevent hemodialysis‐access thrombosis
TL;DR: This work sought to determine the economic value of early angiography and prophylactic angioplasty to prevent hemodialysis‐access thrombosis.
Policy and Practice:The Dilemma
TL;DR: For example, this paper argued that the more aims outstrip capabilities, the less likely is effective implementation, since the key problem solvers are those who have the problem, and the realization of policy in practice depends on the fit between capabilities that support implementation and aims.
Journal ArticleDOI
Health after coronary stenting or balloon angioplasty: results from the Stent Restenosis Study.
Harlan M. Krumholz,David Cohen,Christianna S. Williams,Donald S. Baim,Jeffrey A. Brinker,Henry S. Cabin,Richard R. Heuser,John W. Hirshfeld,Martin B. Leon,Jeffrey W. Moses,Mike Savage,Michael W. Cleman +11 more
TL;DR: This survey revealed no marked differences in long-term HRQOL between patients who underwent Palmaz-Schatz coronary stenting compared with those who underwent conventional angioplasty, and there were no significant differences in generic or disease-specific measures.
Journal ArticleDOI
Temporal Trends in Quality of Life Outcomes After Transapical Transcatheter Aortic Valve Replacement A Placement of AoRTic TraNscathetER Valve (PARTNER) Trial Substudy
Hemal Gada,Ajay J. Kirtane,Kaijun Wang,Yang Lei,Elizabeth A. Magnuson,Matthew R. Reynolds,Mathew R. Williams,Susheel Kodali,Torsten Vahl,Suzanne V. Arnold,Martin B. Leon,Vinod H. Thourani,Wilson Y. Szeto,David Cohen +13 more
TL;DR: HRQoL outcomes remained similar to those of TA-TAVR in the original RCT cohort and no better than those with SAVR, which has important implications for patient selection for TAVR when transfemoral access is not an option.
Journal ArticleDOI
Cost-effectiveness of transcatheter valvular interventions: economic challenges.
TL;DR: Current data suggest that, for patients who are eligible for transfemoral access, TAVI is economically attractive (or even economically dominant) compared with high-risk SAVR, however, the cost-effectiveness of TAVi for patientsWho are not suitable for a transfemmoral approach appears to be less favourable.